Purpose: To use deep learning to improve the image quality of subsampled images (number of acquisitions = 1 [NOA 1]) to reduce whole-body diffusion-weighted MRI (WBDWI) acquisition times.Materials and Methods: Both retrospective and prospective patient groups were used to develop a deep learning-based denoising image filter (DNIF) model. For initial model training and validation, 17 patients with metastatic prostate cancer with acquired WBDWI NOA 1 and NOA 9 images (acquisition period, 2015-2017) were retrospectively included. An additional 22 prospective patients with advanced prostate cancer, myeloma, and advanced breast cancer were used for model testing (2019), and the radiologic quality of DNIF-processed NOA 1 (NOA 1-DNIF) images were compared with NOA 1 images and clinical NOA 16 images by using a three-point Likert scale (good, average, or poor; statistical significance was calculated by using a Wilcoxon signed ranked test). The model was also retrained and tested in 28 patients with malignant pleural mesothelioma (MPM) who underwent lung MRI (2015-2017) to demonstrate feasibility in other body regions.Results: The model visually improved the quality of NOA 1 images in all test patients, with the majority of NOA 1-DNIF and NOA 16 images being graded as either "average" or "good" across all image-quality criteria. From validation data, the mean apparent diffusion coefficient (ADC) values within NOA 1-DNIF images of bone disease deviated from those within NOA 9 images by an average of 1.9% (range, 1.1%-2.6%). The model was also successfully applied in the context of MPM; the mean ADCs from NOA 1-DNIF images of MPM deviated from those measured by using clinical-standard images (NOA 12) by 3.7% (range, 0.2%-10.6%).Conclusion: Clinical-standard images were generated from subsampled images by using a DNIF. Supplemental material is available for this article. Published under a CC BY 4.0 license.
Zormpas Petridis, K., Tunariu, N., Curcean, A., Messiou, C., Curcean, S., Collins, D., Hughes, J., Jamin, Y., Koh, D., Blackledge, M., Accelerating Whole-Body Diffusion-weighted MRI with Deep Learning-based Denoising Image Filters, <<RADIOLOGY. ARTIFICIAL INTELLIGENCE>>, 2021; 3 (5): N/A-N/A. [doi:10.1148/ryai.2021200279] [https://hdl.handle.net/10807/304476]
Accelerating Whole-Body Diffusion-weighted MRI with Deep Learning-based Denoising Image Filters
Zormpas Petridis, Konstantinos;
2021
Abstract
Purpose: To use deep learning to improve the image quality of subsampled images (number of acquisitions = 1 [NOA 1]) to reduce whole-body diffusion-weighted MRI (WBDWI) acquisition times.Materials and Methods: Both retrospective and prospective patient groups were used to develop a deep learning-based denoising image filter (DNIF) model. For initial model training and validation, 17 patients with metastatic prostate cancer with acquired WBDWI NOA 1 and NOA 9 images (acquisition period, 2015-2017) were retrospectively included. An additional 22 prospective patients with advanced prostate cancer, myeloma, and advanced breast cancer were used for model testing (2019), and the radiologic quality of DNIF-processed NOA 1 (NOA 1-DNIF) images were compared with NOA 1 images and clinical NOA 16 images by using a three-point Likert scale (good, average, or poor; statistical significance was calculated by using a Wilcoxon signed ranked test). The model was also retrained and tested in 28 patients with malignant pleural mesothelioma (MPM) who underwent lung MRI (2015-2017) to demonstrate feasibility in other body regions.Results: The model visually improved the quality of NOA 1 images in all test patients, with the majority of NOA 1-DNIF and NOA 16 images being graded as either "average" or "good" across all image-quality criteria. From validation data, the mean apparent diffusion coefficient (ADC) values within NOA 1-DNIF images of bone disease deviated from those within NOA 9 images by an average of 1.9% (range, 1.1%-2.6%). The model was also successfully applied in the context of MPM; the mean ADCs from NOA 1-DNIF images of MPM deviated from those measured by using clinical-standard images (NOA 12) by 3.7% (range, 0.2%-10.6%).Conclusion: Clinical-standard images were generated from subsampled images by using a DNIF. Supplemental material is available for this article. Published under a CC BY 4.0 license.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.